2型糖尿病患者心肾功能降低是STEMI直接PCI后住院不良事件的主要驱动因素
该回顾性研究分析5152例接受直接PCI的STEMI患者,其中879例(17%)合并2型糖尿病。糖尿病患者LVEF≤40%、eGFR≤60 mL/min/1.73 m2或两者兼有的比例均更高。糖尿病患者住院死亡率更高(6.1% vs 3.5%),但校正心肾功能后糖尿病与死亡风险不再相关(OR 1.03,95%CI 0.68-1.56)。
要点
- 糖尿病患者STEMI后住院死亡率更高,但校正心肾功能后差异消失。
- 糖尿病患者LVEF≤40%、eGFR≤60及两者兼有的发生率均显著高于非糖尿病患者。
- 心肾功能降低是糖尿病患者住院不良事件风险增加的主要驱动因素。
核心结论
- 糖尿病患者STEMI直接PCI后住院死亡率和并发症风险增加主要由其潜在的心肾功能降低所驱动。
研究设计与样本
- 回顾性分析5152例接受直接PCI的STEMI患者,入院时评估LVEF和eGFR。
- 主要终点为住院死亡率,次要终点为住院死亡、心源性休克和急性肾损伤的复合终点。
主要发现
- 糖尿病患者879例(17%),其LVEF≤40%发生率30% vs 22%,eGFR≤60 mL/min/1.73 m2发生率27% vs 18%,两者兼有12% vs 6%(P均<0.001)。
- 糖尿病患者住院死亡率6.1% vs 3.5%(P=0.002),未校正OR 1.81(95%CI 1.31-2.49;P<0.001)。
- 校正心肾功能后,糖尿病与住院死亡率无显著关联(OR 1.03,95%CI 0.68-1.56;P=0.89)。
- 次要终点未校正OR 1.52(95%CI 1.25-1.85;P<0.001),校正心肾功能后OR 1.07(95%CI 0.85-1.36;P=0.53)。
临床怎么用
- 对合并糖尿病的STEMI患者应重视入院时心功能(LVEF)和肾功能(eGFR)评估,以识别高危人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: ST-segment elevation myocardial infarction (STEMI) patients with type 2 diabetes mellitus (DM) have higher in-hospital mortality than those without. Since cardiac and renal functions are the main variables associated with outcome in STEMI, we hypothesized that this prognostic disparity may depend on a higher rate of cardiac and renal dysfunction in DM patients. RESEARCH DESIGN AND METHODS: We retrospectively analyzed 5,152 STEMI patients treated with primary angioplasty. Left ventricular ejection fraction (LVEF) and estimated glomerular filtration rate (eGFR) were evaluated at hospital admission. The primary end point was in-hospital mortality. A composite of in-hospital mortality, cardiogenic shock, and acute kidney injury was the secondary end point. RESULTS: There were 879 patients (17%) with DM. The incidence of LVEF ≤40% (30% vs. 22%), eGFR ≤60 mL/min/1.73 m2 (27% vs. 18%), or both (12% vs. 6%) was higher (P < 0.001 for all comparisons) in DM patients. In-hospital mortality was higher in DM patients than in non-DM patients (6.1% vs. 3.5%; P = 0.002), with an unadjusted odds ratio (OR) of 1.81 (95% CI 1.31-2.49; P < 0.001). However, DM was no longer associated with an increased mortality risk after adjustment for cardiac and renal function (OR 1.03, 95% CI 0.68-1.56; P = 0.89). A similar behavior was observed for the secondary end point, with an unadjusted OR for DM of 1.52 (95% CI 1.25-1.85; P < 0.001) and an OR after adjustment for cardiac and renal function of 1.07 (95% CI 0.85-1.36; P = 0.53). CONCLUSIONS: The study indicates that the increased in-hospital mortality and morbidity of DM patients with STEMI is mainly driven by their underlying cardio-renal dysfunction.
引用
- Marenzi G, Cosentino N, Genovese S, et al. Reduced Cardio-Renal Function Accounts for Most of the In-Hospital Morbidity and Mortality Risk Among Patients With Type 2 Diabetes Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Diabetes Care. 2019. PMID: 31048409. doi:10.2337/dc19-0047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。